Royal Bank Of Canada Forecasts Strong Price Appreciation for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) had its target price raised by stock analysts at Royal Bank Of Canada from $26.00 to $38.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the biopharmaceutical company’s stock. Royal Bank Of Canada’s price objective indicates a potential upside of […]
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) had its target price raised by stock analysts at Royal Bank Of Canada from $26.00 to $38.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the biopharmaceutical company’s stock. Royal Bank Of Canada’s price objective indicates a potential upside of […]
-logo-1200x675.png&w=240&h=240&zc=2){kind=logo}
